tm logo
REVNEUZE
ABANDONED SECTION 36

on 28 Jun 2022

Last Applicant/ Owned by

PHARMAZZ INC.

50 West 75th Street, Suite 105Willowbrook IL 60527

US

Serial Number

2030775 filed on 29th Jan 2020

REVNEUZE

Trademark usage description

pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's dise Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, mixed dementia, frontotemporal dementia, dementia with Lewy bodies, vascular dementia, Wernicke-Korsakoff syndrome, Huntington's disease, Creutzfeldt Jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.


Classification kind code

11

Mark Details


Serial Number

2030775

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 05th Apr 2022
Default Notice Sent
Submitted for opposition 22
on 16th Sep 2021
Search Recorded
Submitted for opposition 20
on 16th Sep 2021
Examiner's First Report
Submitted for opposition 223
on 16th Sep 2021
Total Provisional Refusal
Submitted for opposition 256
on 29th Mar 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th May 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th May 2020
Created
Submitted for opposition 31
on 27th May 2020
Formalized
Submitted for opposition 30
on 29th Jan 2020
Filed
Submitted for opposition 228
on 29th Jan 2020
International Registration